The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Crispr Genomic Cure Market Research Report 2025
Synopsis
The global Crispr Genomic Cure market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Crispr Genomic Cure is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Crispr Genomic Cure is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Crispr Genomic Cure in Biomedical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Crispr Genomic Cure include Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine and ERS Genomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Crispr Genomic Cure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crispr Genomic Cure.
Report Scope
The Crispr Genomic Cure market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crispr Genomic Cure market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crispr Genomic Cure companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Applied StemCel
Beam Therapeutics
CALYXT
Cellecta
Cellectis
CRISPR Therapeutics AG
Editas Medicine
ERS Genomics
Integrated DNA Technologies
Intellia Therapeutics
Merck KGaA
New England Biolabs
Precision BioSciences
Sangamo Therapeutics
Segment by Type
gRNA Design and Vector Construction
Cell Line and Engineering
Others
Segment by Application
Biomedical
Pharmaceutical
Agricultural
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crispr Genomic Cure companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Crispr Genomic Cure market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Crispr Genomic Cure is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Crispr Genomic Cure is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Crispr Genomic Cure in Biomedical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Crispr Genomic Cure include Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine and ERS Genomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Crispr Genomic Cure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crispr Genomic Cure.
Report Scope
The Crispr Genomic Cure market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crispr Genomic Cure market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crispr Genomic Cure companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Applied StemCel
Beam Therapeutics
CALYXT
Cellecta
Cellectis
CRISPR Therapeutics AG
Editas Medicine
ERS Genomics
Integrated DNA Technologies
Intellia Therapeutics
Merck KGaA
New England Biolabs
Precision BioSciences
Sangamo Therapeutics
Segment by Type
gRNA Design and Vector Construction
Cell Line and Engineering
Others
Segment by Application
Biomedical
Pharmaceutical
Agricultural
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crispr Genomic Cure companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crispr Genomic Cure Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 gRNA Design and Vector Construction
1.2.3 Cell Line and Engineering
1.2.4 Others
1.3 Market by Application
1.3.1 Global Crispr Genomic Cure Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biomedical
1.3.3 Pharmaceutical
1.3.4 Agricultural
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crispr Genomic Cure Market Perspective (2019-2030)
2.2 Crispr Genomic Cure Growth Trends by Region
2.2.1 Global Crispr Genomic Cure Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Crispr Genomic Cure Historic Market Size by Region (2019-2024)
2.2.3 Crispr Genomic Cure Forecasted Market Size by Region (2025-2030)
2.3 Crispr Genomic Cure Market Dynamics
2.3.1 Crispr Genomic Cure Industry Trends
2.3.2 Crispr Genomic Cure Market Drivers
2.3.3 Crispr Genomic Cure Market Challenges
2.3.4 Crispr Genomic Cure Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crispr Genomic Cure Players by Revenue
3.1.1 Global Top Crispr Genomic Cure Players by Revenue (2019-2024)
3.1.2 Global Crispr Genomic Cure Revenue Market Share by Players (2019-2024)
3.2 Global Crispr Genomic Cure Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Crispr Genomic Cure Revenue
3.4 Global Crispr Genomic Cure Market Concentration Ratio
3.4.1 Global Crispr Genomic Cure Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crispr Genomic Cure Revenue in 2023
3.5 Crispr Genomic Cure Key Players Head office and Area Served
3.6 Key Players Crispr Genomic Cure Product Solution and Service
3.7 Date of Enter into Crispr Genomic Cure Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crispr Genomic Cure Breakdown Data by Type
4.1 Global Crispr Genomic Cure Historic Market Size by Type (2019-2024)
4.2 Global Crispr Genomic Cure Forecasted Market Size by Type (2025-2030)
5 Crispr Genomic Cure Breakdown Data by Application
5.1 Global Crispr Genomic Cure Historic Market Size by Application (2019-2024)
5.2 Global Crispr Genomic Cure Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Crispr Genomic Cure Market Size (2019-2030)
6.2 North America Crispr Genomic Cure Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Crispr Genomic Cure Market Size by Country (2019-2024)
6.4 North America Crispr Genomic Cure Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crispr Genomic Cure Market Size (2019-2030)
7.2 Europe Crispr Genomic Cure Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Crispr Genomic Cure Market Size by Country (2019-2024)
7.4 Europe Crispr Genomic Cure Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crispr Genomic Cure Market Size (2019-2030)
8.2 Asia-Pacific Crispr Genomic Cure Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Crispr Genomic Cure Market Size by Region (2019-2024)
8.4 Asia-Pacific Crispr Genomic Cure Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crispr Genomic Cure Market Size (2019-2030)
9.2 Latin America Crispr Genomic Cure Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Crispr Genomic Cure Market Size by Country (2019-2024)
9.4 Latin America Crispr Genomic Cure Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crispr Genomic Cure Market Size (2019-2030)
10.2 Middle East & Africa Crispr Genomic Cure Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Crispr Genomic Cure Market Size by Country (2019-2024)
10.4 Middle East & Africa Crispr Genomic Cure Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Crispr Genomic Cure Introduction
11.1.4 Abcam Revenue in Crispr Genomic Cure Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 Applied StemCel
11.2.1 Applied StemCel Company Detail
11.2.2 Applied StemCel Business Overview
11.2.3 Applied StemCel Crispr Genomic Cure Introduction
11.2.4 Applied StemCel Revenue in Crispr Genomic Cure Business (2019-2024)
11.2.5 Applied StemCel Recent Development
11.3 Beam Therapeutics
11.3.1 Beam Therapeutics Company Detail
11.3.2 Beam Therapeutics Business Overview
11.3.3 Beam Therapeutics Crispr Genomic Cure Introduction
11.3.4 Beam Therapeutics Revenue in Crispr Genomic Cure Business (2019-2024)
11.3.5 Beam Therapeutics Recent Development
11.4 CALYXT
11.4.1 CALYXT Company Detail
11.4.2 CALYXT Business Overview
11.4.3 CALYXT Crispr Genomic Cure Introduction
11.4.4 CALYXT Revenue in Crispr Genomic Cure Business (2019-2024)
11.4.5 CALYXT Recent Development
11.5 Cellecta
11.5.1 Cellecta Company Detail
11.5.2 Cellecta Business Overview
11.5.3 Cellecta Crispr Genomic Cure Introduction
11.5.4 Cellecta Revenue in Crispr Genomic Cure Business (2019-2024)
11.5.5 Cellecta Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Detail
11.6.2 Cellectis Business Overview
11.6.3 Cellectis Crispr Genomic Cure Introduction
11.6.4 Cellectis Revenue in Crispr Genomic Cure Business (2019-2024)
11.6.5 Cellectis Recent Development
11.7 CRISPR Therapeutics AG
11.7.1 CRISPR Therapeutics AG Company Detail
11.7.2 CRISPR Therapeutics AG Business Overview
11.7.3 CRISPR Therapeutics AG Crispr Genomic Cure Introduction
11.7.4 CRISPR Therapeutics AG Revenue in Crispr Genomic Cure Business (2019-2024)
11.7.5 CRISPR Therapeutics AG Recent Development
11.8 Editas Medicine
11.8.1 Editas Medicine Company Detail
11.8.2 Editas Medicine Business Overview
11.8.3 Editas Medicine Crispr Genomic Cure Introduction
11.8.4 Editas Medicine Revenue in Crispr Genomic Cure Business (2019-2024)
11.8.5 Editas Medicine Recent Development
11.9 ERS Genomics
11.9.1 ERS Genomics Company Detail
11.9.2 ERS Genomics Business Overview
11.9.3 ERS Genomics Crispr Genomic Cure Introduction
11.9.4 ERS Genomics Revenue in Crispr Genomic Cure Business (2019-2024)
11.9.5 ERS Genomics Recent Development
11.10 Integrated DNA Technologies
11.10.1 Integrated DNA Technologies Company Detail
11.10.2 Integrated DNA Technologies Business Overview
11.10.3 Integrated DNA Technologies Crispr Genomic Cure Introduction
11.10.4 Integrated DNA Technologies Revenue in Crispr Genomic Cure Business (2019-2024)
11.10.5 Integrated DNA Technologies Recent Development
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Detail
11.11.2 Intellia Therapeutics Business Overview
11.11.3 Intellia Therapeutics Crispr Genomic Cure Introduction
11.11.4 Intellia Therapeutics Revenue in Crispr Genomic Cure Business (2019-2024)
11.11.5 Intellia Therapeutics Recent Development
11.12 Merck KGaA
11.12.1 Merck KGaA Company Detail
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Crispr Genomic Cure Introduction
11.12.4 Merck KGaA Revenue in Crispr Genomic Cure Business (2019-2024)
11.12.5 Merck KGaA Recent Development
11.13 New England Biolabs
11.13.1 New England Biolabs Company Detail
11.13.2 New England Biolabs Business Overview
11.13.3 New England Biolabs Crispr Genomic Cure Introduction
11.13.4 New England Biolabs Revenue in Crispr Genomic Cure Business (2019-2024)
11.13.5 New England Biolabs Recent Development
11.14 Precision BioSciences
11.14.1 Precision BioSciences Company Detail
11.14.2 Precision BioSciences Business Overview
11.14.3 Precision BioSciences Crispr Genomic Cure Introduction
11.14.4 Precision BioSciences Revenue in Crispr Genomic Cure Business (2019-2024)
11.14.5 Precision BioSciences Recent Development
11.15 Sangamo Therapeutics
11.15.1 Sangamo Therapeutics Company Detail
11.15.2 Sangamo Therapeutics Business Overview
11.15.3 Sangamo Therapeutics Crispr Genomic Cure Introduction
11.15.4 Sangamo Therapeutics Revenue in Crispr Genomic Cure Business (2019-2024)
11.15.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Crispr Genomic Cure Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of gRNA Design and Vector Construction
Table 3. Key Players of Cell Line and Engineering
Table 4. Key Players of Others
Table 5. Global Crispr Genomic Cure Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Crispr Genomic Cure Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Crispr Genomic Cure Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Crispr Genomic Cure Market Share by Region (2019-2024)
Table 9. Global Crispr Genomic Cure Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Crispr Genomic Cure Market Share by Region (2025-2030)
Table 11. Crispr Genomic Cure Market Trends
Table 12. Crispr Genomic Cure Market Drivers
Table 13. Crispr Genomic Cure Market Challenges
Table 14. Crispr Genomic Cure Market Restraints
Table 15. Global Crispr Genomic Cure Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Crispr Genomic Cure Market Share by Players (2019-2024)
Table 17. Global Top Crispr Genomic Cure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crispr Genomic Cure as of 2023)
Table 18. Ranking of Global Top Crispr Genomic Cure Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Crispr Genomic Cure Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Crispr Genomic Cure Product Solution and Service
Table 22. Date of Enter into Crispr Genomic Cure Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Crispr Genomic Cure Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Crispr Genomic Cure Revenue Market Share by Type (2019-2024)
Table 26. Global Crispr Genomic Cure Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Crispr Genomic Cure Revenue Market Share by Type (2025-2030)
Table 28. Global Crispr Genomic Cure Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Crispr Genomic Cure Revenue Market Share by Application (2019-2024)
Table 30. Global Crispr Genomic Cure Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Crispr Genomic Cure Revenue Market Share by Application (2025-2030)
Table 32. North America Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Crispr Genomic Cure Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Crispr Genomic Cure Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Crispr Genomic Cure Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Crispr Genomic Cure Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Crispr Genomic Cure Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Crispr Genomic Cure Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Crispr Genomic Cure Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Crispr Genomic Cure Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Crispr Genomic Cure Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Crispr Genomic Cure Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Crispr Genomic Cure Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abcam Company Detail
Table 48. Abcam Business Overview
Table 49. Abcam Crispr Genomic Cure Product
Table 50. Abcam Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Applied StemCel Company Detail
Table 53. Applied StemCel Business Overview
Table 54. Applied StemCel Crispr Genomic Cure Product
Table 55. Applied StemCel Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 56. Applied StemCel Recent Development
Table 57. Beam Therapeutics Company Detail
Table 58. Beam Therapeutics Business Overview
Table 59. Beam Therapeutics Crispr Genomic Cure Product
Table 60. Beam Therapeutics Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 61. Beam Therapeutics Recent Development
Table 62. CALYXT Company Detail
Table 63. CALYXT Business Overview
Table 64. CALYXT Crispr Genomic Cure Product
Table 65. CALYXT Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 66. CALYXT Recent Development
Table 67. Cellecta Company Detail
Table 68. Cellecta Business Overview
Table 69. Cellecta Crispr Genomic Cure Product
Table 70. Cellecta Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 71. Cellecta Recent Development
Table 72. Cellectis Company Detail
Table 73. Cellectis Business Overview
Table 74. Cellectis Crispr Genomic Cure Product
Table 75. Cellectis Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 76. Cellectis Recent Development
Table 77. CRISPR Therapeutics AG Company Detail
Table 78. CRISPR Therapeutics AG Business Overview
Table 79. CRISPR Therapeutics AG Crispr Genomic Cure Product
Table 80. CRISPR Therapeutics AG Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 81. CRISPR Therapeutics AG Recent Development
Table 82. Editas Medicine Company Detail
Table 83. Editas Medicine Business Overview
Table 84. Editas Medicine Crispr Genomic Cure Product
Table 85. Editas Medicine Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 86. Editas Medicine Recent Development
Table 87. ERS Genomics Company Detail
Table 88. ERS Genomics Business Overview
Table 89. ERS Genomics Crispr Genomic Cure Product
Table 90. ERS Genomics Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 91. ERS Genomics Recent Development
Table 92. Integrated DNA Technologies Company Detail
Table 93. Integrated DNA Technologies Business Overview
Table 94. Integrated DNA Technologies Crispr Genomic Cure Product
Table 95. Integrated DNA Technologies Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 96. Integrated DNA Technologies Recent Development
Table 97. Intellia Therapeutics Company Detail
Table 98. Intellia Therapeutics Business Overview
Table 99. Intellia Therapeutics Crispr Genomic Cure Product
Table 100. Intellia Therapeutics Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 101. Intellia Therapeutics Recent Development
Table 102. Merck KGaA Company Detail
Table 103. Merck KGaA Business Overview
Table 104. Merck KGaA Crispr Genomic Cure Product
Table 105. Merck KGaA Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 106. Merck KGaA Recent Development
Table 107. New England Biolabs Company Detail
Table 108. New England Biolabs Business Overview
Table 109. New England Biolabs Crispr Genomic Cure Product
Table 110. New England Biolabs Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 111. New England Biolabs Recent Development
Table 112. Precision BioSciences Company Detail
Table 113. Precision BioSciences Business Overview
Table 114. Precision BioSciences Crispr Genomic Cure Product
Table 115. Precision BioSciences Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 116. Precision BioSciences Recent Development
Table 117. Sangamo Therapeutics Company Detail
Table 118. Sangamo Therapeutics Business Overview
Table 119. Sangamo Therapeutics Crispr Genomic Cure Product
Table 120. Sangamo Therapeutics Revenue in Crispr Genomic Cure Business (2019-2024) & (US$ Million)
Table 121. Sangamo Therapeutics Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crispr Genomic Cure Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Crispr Genomic Cure Market Share by Type: 2023 VS 2030
Figure 3. gRNA Design and Vector Construction Features
Figure 4. Cell Line and Engineering Features
Figure 5. Others Features
Figure 6. Global Crispr Genomic Cure Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Crispr Genomic Cure Market Share by Application: 2023 VS 2030
Figure 8. Biomedical Case Studies
Figure 9. Pharmaceutical Case Studies
Figure 10. Agricultural Case Studies
Figure 11. Others Case Studies
Figure 12. Crispr Genomic Cure Report Years Considered
Figure 13. Global Crispr Genomic Cure Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Crispr Genomic Cure Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Crispr Genomic Cure Market Share by Region: 2023 VS 2030
Figure 16. Global Crispr Genomic Cure Market Share by Players in 2023
Figure 17. Global Top Crispr Genomic Cure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crispr Genomic Cure as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Crispr Genomic Cure Revenue in 2023
Figure 19. North America Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Crispr Genomic Cure Market Share by Country (2019-2030)
Figure 21. United States Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Crispr Genomic Cure Market Share by Country (2019-2030)
Figure 25. Germany Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Crispr Genomic Cure Market Share by Region (2019-2030)
Figure 33. China Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Crispr Genomic Cure Market Share by Country (2019-2030)
Figure 41. Mexico Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Crispr Genomic Cure Market Share by Country (2019-2030)
Figure 45. Turkey Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Crispr Genomic Cure Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Abcam Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 48. Applied StemCel Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 49. Beam Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 50. CALYXT Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 51. Cellecta Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 52. Cellectis Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 53. CRISPR Therapeutics AG Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 54. Editas Medicine Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 55. ERS Genomics Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 56. Integrated DNA Technologies Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 57. Intellia Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 58. Merck KGaA Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 59. New England Biolabs Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 60. Precision BioSciences Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 61. Sangamo Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
